Divi's Lab. (DIVISLAB)

FairStock Score: 54/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Fortress balance sheet: D/E only 0.01, Altman Z-Score 8.17, and FCF of ₹849 Cr.
• High returns on capital: ROE 16.56% and ROCE 20.44% indicate a quality franchise.
• Recent momentum: sales grew 13.62% and net profit 19.93%; latest quarterly sales ₹2,604 Cr and PAT ₹583 Cr.
• Healthy fundamentals per Piotroski F-Score 8/9 and promoter holding of 51.88%.

Concerns

• Extreme valuation: P/E 67.16 and P/B 11.31 with PEG 4.35 leave no margin of safety.
• Graham Number ₹1,088.39 and DCF intrinsic value ₹524.98 are far below the current price ₹6,378.75.
• 5-year revenue CAGR of only 6.08% does not justify a high-multiple growth premium.
• Low dividend yield of 0.47% offers little compensation while waiting for growth.

AI Analysis

Let me look at Divi's Lab as an owner, not a trader. Quality is not the problem. This is a financially exceptional business: return on equity is 16.56%, return on capital employed is 20.44%, debt is almost nonexistent at 0.01 times equity, and free cash flow is ₹849 crore. The Piotroski score of 8/9 and Altman Z of 8.17 tell me the balance sheet is a fortress. Promoters own 51.88%, so my interests are aligned. The latest quarter shows sales of ₹2,604 crore and net profit of ₹583 crore, with sales up 13.62% and profit up 19.93%. That momentum is real. But valuation stops me cold. At ₹6,378.75, the market cap is ₹1.70 lakh crore. I am being asked to pay 67.16 times earnings and 11.31 times book value, with a dividend yield of 0.47%. The PEG ratio of 4.35 says the growth is already more than paid for. Graham's defensive number is ₹1,088.39, and DCF says ₹524.98; my margin of safety is minus 488.81%. That is not investing, it is hope. Worse, the 5-year revenue CAGR is only 6.08%. A company growing revenue in the mid single digits over a cycle does not deserve a 67 P/E, no matter how good the business. The recent acceleration in sales and profit is encouraging, but I cannot rely on a few quarters to justify a price six times Graham's estimate. Even a wonderful business purchased at too high a price can produce poor returns. Divi's is a fine company, but the price embeds enormous optimism. As Graham said, price is what you pay, value is what you get. Here I would get far less. I would wait for a margin of safety.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer